Farmacenter
Timeline
17 events since 2018Board
Filings
Financial
Establishments
20182020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBabbreviated format · 31 days before the deadline
2025
Annual accounts 2024 filed PDFabbreviated format · 6 days before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:0716974906
2024
Highest result from 2019 to 2025 net €125,374 ▲5.7% The operating result of €132,703 and the net result of €125,374 are both a record.
Annual accounts 2023 filed PDFabbreviated format · 1 day before the deadline
2023
Annual accounts 2022 filed PDFabbreviated format · 29 days late
2 directors appointed, 2 resignationsResignations: Luc Maisin and Michel Maisin · Appointments: BV Kaat Strybol Pharma and BV LUNSIEFAR · Director discharge: Luc Maisin · General meeting of 31-03-20237 points ▸
- General meeting, 31-03-2023
- Director resignation, Luc Maisin
- Director resignation, Michel Maisin
- Director discharge, Luc Maisin
- Director discharge, Michel Maisin
- Director appointment, BV Kaat Strybol Pharma
- Director appointment, BV LUNSIEFAR
2022
Changes of role: MAISIN Luc (director) and MAISIN Michel (director)Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 14-09-20227 points ▸
- General meeting, 14-09-2022
- Legal-form conversion, from private limited company (pre-2019) to private limited company
- Director resignation, MAISIN Luc (manager)
- Director resignation, MAISIN Michel (manager)
- Director appointment, MAISIN Luc (director (not named in the articles))
- Director appointment, MAISIN Michel (director (not named in the articles))
- Registered office clause, Waversesteenweg 22, 3090 Overijse
- The deed holds 4 more points.
Annual accounts 2021 filed PDFabbreviated format · 51 days before the deadline
2021
Back to profit net €73,340 The net result is €73,340, after one loss-making year.
Equity above €500,000 equity €531,634 ▲16% Equity rises from €458,359 to €531,634.
Annual accounts 2020 filed PDFabbreviated format · 28 days late
2020
Weakest financial year net -€27,577 The net result drops to -€27,577, the lowest from 2019 to 2025. It recovers the following year.
Annual accounts 2019 filed PDFabbreviated format · 87 days late
2019
Annual accounts 2018 filed PDFabbreviated format · 70 days late
First establishment Waversesteenweg 22, Overijse
2018
IncorporationDemerger: Maisin splits off to Farmacenter · Capital of €328,178.62, 420 shares · Appointments: Michel Maisin (manager) and Luc Maisin (manager) · published on 11-01-20194 points ▸
- General meeting, 20-12-2018
- Capital, €328,178.62, 420 shares
- Director appointment, Michel Maisin (manager)
- Director appointment, Luc Maisin (manager)
- The deed holds 6 more points.
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank